Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level

Thrombosis and Haemostasis

Volumn 102, Issue 1, 2009, Pages 131-136

  Le Cam Duchez, Véronique ^a,b,g   Soria, Claudine ^b,c   Bal Dit Sollier, Claire ^c   Borg, Jeanne Yvonne ^a,b   Coudert, Mathieu ^d,e   Montalescot, Gilles ^f   Esposito, Gaétan ^c   Drouet, Ludovic ^c   Collet, Jean Philippe ^f  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Genetics; Myocardial infarction; Polymorphism; Protein Z; Young adults

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE OF ONSET; BLOOD PROTEINS; FACTOR XA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 67749106111     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-01-0007     Document Type: Article

References (37)

1. Broze GJ, Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost 2001; 86: 8-13.
2. Tabatabai A, Fiehler R, Broze GJ, Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 2001; 85: 655-660.
3. Kemkes-Matthes B, Nees M, Kuhnel G, et al. Protein Z influences the prothrombotic phenotype in Factor V Leiden patients. Thromb Res 2002; 106: 183-185.
4. Greten J, Kreis I, Liliensiek B, et al. Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa 1998; 27: 144-148.
5. Kobelt K, Biasiutti FD, Mattle HP, et al. Protein Z in ischaemic stroke. Br J Haematol 2001; 114: 169-173.
6. Vasse M, Guegan-Massardier E, Borg JY, Woimant F, Soria C. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001; 357: 933-934.
7. Heeb MJ, Paganini-Hill A, Griffin JH, Fisher M. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-144.
8. Fedi S, Sofi F, Brogi D, et al. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003; 90: 1173-1178.
9. Morange PE, Juhan-Vague I. Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME Study. J Thromb Haemost 2004; 2: 2050-2051.
10. Sofi F, Cesari F, Pratesi G, et al. Low protein Z levels in patients with peripheral arterial disease. Thromb Haemost 2007; 98: 1114-1117.
11. Sofi F, Cesari F, Marcucci R, et al. Protein Z levels and prognosis in patients with acute coronary syndromes. Clin Chem Lab Med 2006; 44: 1098-1102.
12. Vasse M, Denoyelle C, Legrand E, Vannier JP, Soria C. Weak regulation of protein Z biosynthesis by inflammatory cytokines. Thromb Haemost 2002; 87: 350-351.
13. Staton J, Sayer M, Hankey GJ, et al. Protein Z gene polymorphisms, protein Z concentrations, and ischemic stroke. Stroke 2005; 36: 1123-1127.
14. Santacroce R, Cappucci F, Di Perna P, Sessa F, Margaglione M. Protein Z gene polymorphisms are associated with protein Z plasma levels. J Thromb Haemost 2004; 2: 1197-1199.
15. Rice GI, Futers TS, Grant PJ. Identification of novel polymorphisms within the protein Z gene, haplotype distribution and linkage analysis. Thromb Haemost 2001; 85: 1123-1124.
16. Cesari F, Fatini C, Sticchi E, et al. Protein Z gene polymorphisms (intron F 79 G>A; -13 A>G) are not associated with acute coronary syndromes. Thromb Haemost 2006; 96: 98-99.
17. Le Cam-Duchez V, Barbay V, Bal dit Sollier C, et al. Haplotypic or genotypic combinations of three PZ polymorphisms influence Protein Z plasma level. Thromb Haemost 2009; 101: 212-214.
18. Le Cam-Duchez V, Bagan-Triquenot A, Barbay V, et al. The G79A polymorphism of protein Z gene is an independant risk factor for cerebral venous thrombosis. J Neurol 2008; 255: 1521-1525.
19. Montalescot G, Collet JP, Tanguy ML, et al. Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin. Circulation 2004; 110: 392-398.
20. Mazoyer E, Ripoll L, Gueguen R, et al. Environmental and genetic influences on fibrinogen level differently evidenced according to the technique of fibrinogen measurement: FITE NAT multicenter study. Thromb Haemost 2001; Suppl: Abstract 2197.
21. Lichy C, Kropp S, Dong-Si T, et al. A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 2004; 35: 40-45.
22. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
23. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
24. Ardissino D, Mannucci PM, Merlini PA, et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 46-51.
25. Barbash GI, White HD, Modan M, et al. Acute myocardial infarction in the young - the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J 1995; 16: 313-316.
26. Fournier JA, Sanchez-Gonzalez A, Quero J, et al. Normal angiogram after myocardial infarction in young patients: a prospective clinical-angiographic and long-term follow-up study. Int J Cardiol 1997; 60: 281-287.
27. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-658.
28. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
29. Middendorf K, Gohring P, Huehns TY, et al. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction. Am Heart J 2004; 147: 897-904.
30. Segev A, Ellis MH, Segev F, et al. High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors. Int J Cardiol 2005; 98: 421-424.
31. Atherosclerosis tavbisg. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 2003; 107: 1117-1122.
32. Boekholdt SM, Kramer MH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost 2007; 33: 588-596.
33. Linnemann B, Schindewolf M, Zgouras D, et al. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Thromb Res 2008; 121: 743-750.
34. Zee RY, Cook NR, Cheng S, et al. Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost 2006; 4: 341-348.
35. Sofi F, Lari B, Rogolino A, Marcucci R, Pratesi G, Dorigo W, et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 2005; 41: 255-260.
36. Vasse M. Protein Z, a protein seeking a pathology. Thromb Haemost 2008; 100: 548-556.
37. Ndonwi M, Lu L, Tu Y, et al. Functional analysis of protein Z (Arg255His) and protein Z-dependent protease inhibitor (Lys25Arg and Ser40Gly) polymorphisms. Br J Haematol 2008; 143: 298-300.